OneSource Specialty Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹428.22 crore, reflecting a quarter-on-quarter *(QoQ) increase of 47.49 per cent from ₹290.34 crore. This corresponds to a year-on-year *(YoY) growth of 0.53 per cent.
Operating Profit
Operating Profit stands at ₹91.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 798.53 per cent from ₹10.23 crore. This corresponds to a year-on-year *(YoY) decline of 49.44 per cent.
PBDT
PBDT stands at ₹71.54 crore, reflecting a quarter-on-quarter *(QoQ) increase of 406.12 per cent from ₹-23.37 crore. This corresponds to a year-on-year *(YoY) decline of 52.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-0.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 99.69 per cent from ₹-93.01 crore. This corresponds to a year-on-year *(YoY) decline of 100.35 per cent.
Net Profit
Net Profit stands at ₹4.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 105.19 per cent from ₹-88.70 crore. This represents a 95.33 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
OneSource Specialty Pharma Ltd Earnings
- YOY
- QOQ
OneSource Specialty Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
OneSource Specialty Pharma Ltd Research Reports
OneSource Specialty Pharma Ltd Financial Reports
OneSource Specialty Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| OneSource Speci. | 0.00% | -5.18% | -13.51% | 15.30% | -10.16% | -21.78% |
| ERIS Lifescience | 1.39% | 3.31% | 9.27% | 10.47% | -3.15% | -9.10% |
| Granules India | 0.39% | 0.73% | 3.94% | 25.34% | 27.66% | 59.51% |
| Caplin Point Lab | 0.20% | 5.32% | 19.75% | 55.73% | 29.55% | 17.89% |
| Cohance Life | 0.46% | 11.15% | 5.83% | 50.40% | -14.41% | -53.05% |
| Natco Pharma | 0.00% | 1.29% | -23.72% | -8.12% | -1.48% | 1.79% |
| Jubilant Pharmo | -0.12% | 0.05% | -3.18% | 12.74% | -9.24% | -17.63% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Managing Director & CEO : Neeraj Sharma
Independent Non Exe. Director : Debarati Sen
Independent Non Exe. Director : Claudio Albrecht
Independent Non Exe. Director : Rashmi Harshadrai Barbhaiya
Independent Non Exe. Director : Vijay Paul Karwal
Independent Non Exe. Director : Colin Michael Bond
Non Executive Director : Bharat Shah
Company Sec. & Compli. Officer : Trisha A